Prolyl 4-hydroxylase, beta polypeptide (P4HB) protein has been found to be associated with tumorigenesis many types of tumor, However, the relationship between P4HB and clear cell renal cell carcinoma (ccRCC) has not been clarified. In this study, we
Purpose: Clear cell renal cell carcinoma (ccRCC) is among the most common malignant tumors worldwide, with a high incidence rate and poor prognosis. Currently, there are no biomarkers that can accurately guide prognostic evaluation and therapeutic strategy for ccRCC. The prognostic value and potential biological function of claudin-8 (CLDN8), a critical component of tight junctions in ccRCC, remain unclear. Methods: Sequencing data were obtained from The Cancer Genome Atlas, International Cancer Genome Consortium, and Gene Expression Omnibus databases. R packages were used to explore CLDN8 mRNA expression levels and analyze differentially expressed genes. Results were validated in clinical specimens and cell lines, and bioinformatics analyses were conducted to explore the potential biological functions of CLDN8. Finally, functional analyses were carried out using 786–O ccRCC cell line. Results: Both CLDN8 mRNA and protein expression levels were significantly lower in ccRCC compared with the normal control tissues. Kaplan–Meier analyses showed that low CLDN8 expression levels were associated with the poor overall survival, while univariate and multivariate Cox regression indicated that CLDN8 could serve as an independent prognostic factor in patient with ccRCC. Bioinformatic and Western blot analyses showed that CLDN8 suppressed proliferation, migration, and invasion of 786–O ccRCC cells through the epithelial–mesenchymal transition and AKT pathways. Conclusion: CLDN8 could serve as an independent prognostic factor in ccRCC, in which it suppresses 786–O proliferation, migration, and invasion through EMT and AKT pathways.
The treatment of urethral stricture disease and the prevention of restenosis present considerable challenges in the field of urology. Tissue-engineered materials, particularly bacterial cellulose scaffolds, have emerged as promising solutions due to their abundant sources, excellent mechanical properties, and biocompatibility. However, for attaining superior treatment for patients with USD, further modification of bacterial cellulose is necessary. We have fabricated a dual-network scaffold with enhanced antibacterial properties and cytokines absorption ability through in-situ polymerization of cationic polyurethane micelles and cyclodextrin on oxidized bacterial cellulose. This scaffold also enables long-term sustained release of loaded drug components. Animal model studies have confirmed that this scaffold can achieve urethral repair outcomes comparable to those of normal urethral tissue. This innovative material provides a robust foundation for advancing new concepts and methodologies in the treatment of urethral stricture disease, potentially transforming clinical approaches to this challenging condition.
BackgroundRenal cell carcinoma is gradually characteristic of the accumulation of lipid-reactive oxygen species. And, the ferroptosis-related LncRNAs have been reported strongly correlated with tumorigenesis and progression. However, the further functions of ferroptosis-related LncRNAs in clear cell renal cell carcinoma have not been explored. MethodsAfter sample cleaning, data integration, and batch effect removal, we used the Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) public database to screen out the expression and prognostic value of ferroptosis-related LncRNAs and then performed the molecular subtyping. The molecular subtyping was developed using the K-means. Then, the KEGG pathway enrichment and statistical analyses of the immune microenvironment and clusters were carried out. The outcomes indicated significant differences in the immune microenvironment and potential therapeutic targets between the two clusters. Then, LASSO Cox regression was performed to establish the 5-LncRNAs-based prognostic signature. The signature could accurately predict patient prognosis and be used as an independent clinical risk factor. And the 5 LncRNAs were validated in the cell lines and clinical samples. We then combined significant clinical parameters in multivariate Cox regression and prognostic signature to construct a clinical predictive nomogram, which provides appropriate guidance for predicting the overall survival of ccRCC patients.ResultsThe prognostic DEFRLncRNAs were identified, and 5 LncRNAs were finally utilized to establish the prognostic signature in the TCGA cohort, which was subsequently validated in the internal and external cohorts. Moreover, we conducted the molecular subtyping and divided the patients in the TCGA cohort into two clusters, showing the difference in the Hallmark pathways, immune infiltration, expression of the immune target, and drug therapy. Furthermore, the nomogram was established better to predict the clinical outcomes of the ccRCC patients. ConclusionsOur study conducted molecular subtyping and established a novel predictive signature based on the ferroptosis-related LncRNAs, which could accurately predict prognosis and potential therapeutic targets in ccRCC patients.